San Diego Business Journal

Recent Stories

Tease photo

DexCom Cements Place in the Market, Valuation Climbs

Shares of locally based DexCom Inc. have soared this month following news that patients will have easier access to the medical device maker’s main product.

Tease photo

Co. Delivers a Who’s Who of Startup Services

Ryan Mickle, a local startup CEO, has launched a website to help fellow entrepreneurs wade through stacks of referrals.

Cytori Therapeutics Acquires San Antonio-Based Pharma Co.

Local cell therapy company Cytori Therapeutics Inc. is acquiring San Antonio-based Azaya Therapeutics for up to $170 million.

Tease photo

Schools Are Out For Underground Elephant

TECH: Course Correction Put Marketing Company In Pursuit of New Verticals

Anyone who has walked past Underground Elephant’s new downtown digs knows that the adtech firm is anything but underground.

Synthetic Genomics Inks Research Deal With Exxon

U.S. oil giant Exxon Mobil Corp. has renewed a deal with local biotech Synthetic Genomics Inc. to jointly research algae biofuels.

FDA Grants aTyr Pharma Fast-Track Status

Shares of drugmaker aTyr Pharma climbed over 30 percent Wednesday following news that the San Diego firm’s drug should progress quickly through the regulatory process.

Tease photo

The Other Startup Cost: Paying the Emotional Price

Depression and stress don’t often come up in gatherings of young entrepreneurs, but the topic struck a chord at Startup Grind’s first meeting of the year.

Tease photo

DexCom CGM Device Is the First of Its Kind to Get Medicare, Medicaid Reimbursement

Shares of locally-based DexCom Inc. skyrocketed 26 percent January 13 following news that patients will have easier access to the medical device maker’s lead product.

Tease photo

DexCom CGM Device Is First of Its Kind to Get Medicare, Medicaid Reimbursement

Shares of locally-based DexCom Inc. skyrocketed 26 percent January 13 following news that patients will have easier access to the medical device maker’s lead product.

Vista-Based Access Biologics Sells Minority Stake for $51 Million

Local biotech Access Biologics has sold a minority stake of the company for $51 million to Barcelona-based pharmaceutical and chemical firm, Grifols.

More stories